StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report released on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Shares of NASDAQ:SRNE opened at $0.01 on Monday. Sorrento Therapeutics has a 12-month low of $0.00 and a 12-month high of $0.25. The stock’s 50-day moving average price is $0.01 and its two-hundred day moving average price is $0.02.
Sorrento Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Sorrento Therapeutics
- Options Trading – Understanding Strike Price
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- Overbought Stocks Explained: Should You Trade Them?
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.